Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers.
暂无分享，去创建一个
Leonard D. Goldstein | R. Gentleman | F. Gnad | James Lee | A. Daemen | S. Seshagiri | Jens Reeder | D. Stokoe | C. Klijn | D. Shames | L. Goldstein | C. Bakalarski | J. Chmielecki | R. Hartmaier | Annalisa Schaub | Thomas Holcomb | Florian Gnad